ID   NW1539
AC   CVCL_S590
SY   NW-1539; NW-MEL-1539; NW-Mel-1539
DR   BTO; BTO_0005427
DR   Wikidata; Q54931193
RX   PubMed=12747757;
RX   PubMed=15087389;
CC   HLA typing: A*03,11; B*44,51; C*w04,w05 (PubMed=12747757).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 7
//
RX   PubMed=12747757;
RA   Jager E., Karbach J., Gnjatic S., Jager D., Maeurer M.J., Atmaca A.,
RA   Arand M., Skipper J.C.A., Stockert E., Chen Y.-T., Old L.J., Knuth A.;
RT   "Identification of a naturally processed NY-ESO-1 peptide recognized
RT   by CD8+ T cells in the context of HLA-B51.";
RL   Cancer Immun. 2:12-12(2002).
//
RX   PubMed=15087389; DOI=10.1158/0008-5472.CAN-03-1054;
RA   Ludwig R.J., Boehme B., Podda M., Henschler R., Jager E., Tandi C.,
RA   Boehncke W.-H., Zollner T.M., Kaufmann R., Gille J.;
RT   "Endothelial P-selectin as a target of heparin action in experimental
RT   melanoma lung metastasis.";
RL   Cancer Res. 64:2743-2750(2004).
//